Maestros Electronics Q1 Results: Net profit flat, revenue down 7.4%
Maestros Electronics reported Q1FY27 standalone net profit of ₹152.61 lakh, essentially flat versus ₹151.75 lakh in Q1FY26. Consolidated net profit rose to ₹167.38 lakh from ₹153.30 lakh. Standalone revenue declined 7.4% YoY to ₹965.94 lakh, driven by weakness in the medical and telemedicine segments. The Board approved a 2.5x increase in authorized share capital to ₹15 crore.

*this image is generated using AI for illustrative purposes only.
Maestros Electronics & Telecommunication Systems Limited reported a standalone net profit of ₹152.61 lakh for the quarter ended June 30, 2026 (Q1FY27), compared to ₹151.75 lakh in the same period of FY26. Consolidated net profit stood at ₹167.38 lakh, up from ₹153.30 lakh year-on-year.
Revenue from operations on a standalone basis fell 7.4% year-on-year to ₹965.94 lakh from ₹1,043.07 lakh. Consolidated revenue also declined, logging ₹1,009.17 lakh against ₹1,043.07 lakh in Q1FY26. The sequential decline in revenue was more pronounced, with standalone topline dropping from ₹1,170.42 lakh in Q4FY26.
Segment Performance
The medical segment remained the primary revenue driver, contributing ₹955.18 lakh (98.9% of total standalone revenue). However, this represented a decline from ₹1,034.90 lakh in Q1FY26 and ₹1,040.22 lakh in the preceding quarter.
The telemedicine segment saw a significant contraction, with revenue falling to ₹2.09 lakh from ₹124.08 lakh in Q4FY26 and nil in Q1FY26. This segment contributed 0.45 lakh to segment results, down sharply from ₹120.84 lakh in the previous quarter. The electronics and instrumentation segment logged revenue of ₹8.68 lakh, up from ₹8.17 lakh year-on-year.
What the Numbers Show
Cost of materials consumed decreased to ₹527.57 lakh (standalone) from ₹614.94 lakh in Q1FY26, aligning with the lower revenue base. Employee benefit expenses rose to ₹141.58 lakh from ₹119.89 lakh year-on-year, indicating fixed cost pressure despite lower volumes. Other income contributed ₹50.66 lakh to standalone total income, constituting approximately 5% of the top line, similar to the 4.9% share in Q1FY26.
Corporate Actions
The Board of Directors, in its meeting held on August 12, 2026, approved:
- An increase in authorized share capital from ₹6 crore (60 lakh equity shares of ₹10 each) to ₹15 crore (1.5 crore equity shares of ₹10 each), subject to shareholder approval.
- Re-appointment of Mr. Prakash Vithal Page as an Independent Director for a term of five years, effective February 5, 2027.
Motilal & Associates LLP served as the independent auditor for both standalone and consolidated financial results.
Historical Stock Returns for Maestros Electronics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.48% | -3.22% | +5.24% | +18.11% | +5.06% | +248.34% |
What strategic initiatives is Maestros Electronics planning to implement to reverse the 7.4% year-on-year revenue decline in its core medical segment?
How will the proposed increase in authorized share capital from ₹6 crore to ₹15 crore impact future fundraising capabilities or potential equity dilution for existing shareholders?
Given the sharp contraction in the telemedicine segment, does management intend to divest this unit or reinvest to stabilize its performance in upcoming quarters?





























